Categories: News

BioMech Wins Best Overall Biometric Solution in 2022 AI Breakthrough Awards

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Award recognizes BioMech Lab™ for its use of motion as a functional biomarker to quantify relevant aspects of physical, surgical, pharmaco and cognitive therapies

RICHMOND, Va., June 29, 2022 /PRNewswire/ — BioMech Health, a division of BioMech Holdings, LLC which provides clinically actionable solutions to improve health, quality of life and performance, announced today that it has received the award for “Best Overall Biometric Solution” in the fifth annual AI Breakthrough Awards. The award recognizes BioMech Lab™ for its use of motion as a functional biomarker to quantify relevant aspects of physical, surgical, pharmaco and cognitive therapies.

“We are very pleased that our AI solutions are having an impact and improving healthcare,” said BioMech founder Frank Fornari, Ph.D. “Being recognized as the Best Overall Biometric Solution by the AI Breakthrough Awards is a real honor and a testament to our team’s hard work and innovation.”

BioMech Lab™ provides clinicians with the ability to capture – in real-time – the relevant motion metrics necessary to rapidly evaluate, design and monitor physical, surgical, pharmaco and cognitive therapies. Coupling advanced sensor technology with powerful artificial intelligence (AI) and machine learning (ML) algorithms and interactive biofeedback, BioMech Lab captures motion data in clinical or real-world settings to deliver precise, accurate and reproducible assessments and treatment modifications that stratify risk and improve care outcomes.

“Functional motion is a powerful measure of health and includes such fundamental aspects as balance, symmetry, range of motion, voluntary motor responses to stimuli and complex movements like gait,” said Fornari. “With BioMech Lab, clinicians can fully and accurately assess these critical aspects of motion, design treatments and monitor and report outcomes for numerous standard tests and clinical conditions – meaning virtually any clinical specialty can now perform medically necessary tests at the appropriate frequency as part of a comprehensive diagnosis and treatment plan.”

BioMech Lab is applicable to multiple specialties. With secure and immediate access via mobile devices and/or a user-friendly web interface, it improves treatment outcomes by:

  • Noninvasively capturing normal and pathological motion
  • Longitudinally assessing progress and, when necessary, modifying treatment
  • Enabling evidence-based clinician-patient interaction and engagement
  • Providing secure, anytime-anywhere cloud-based access to patient metrics and reports in a HIPAA-compliant Laboratory Information System

The AI Breakthrough Awards recognize innovation across a range of AI and machine learning-related categories, including AI platforms, deep learning, business intelligence, natural language processing and industry-specific AI applications. Market intelligence analysts from AI Breakthrough evaluated nearly 3,000 nominations from around the world, reviewing, scoring and analyzing each entry to name the top performers.

Click here to see BioMech Lab in action.

About BioMech

Headquartered in Richmond, Va, BioMech is a leading-edge biotechnology company that develops and distributes real-time motion analytics and artificial intelligence/machine learning solutions, including BioMech Lab™ and Coretex™ that quantify and improve outcomes in healthcare, sports/wellness and industrial sectors. For more information, visit www.biomech.us.

Media Contact

Kent Ha
Firecracker PR
339628@email4pr.com 
1-888-317-4687 ext. 708

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomech-wins-best-overall-biometric-solution-in-2022-ai-breakthrough-awards-301577857.html

SOURCE BioMech Holdings, LLC

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

3 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

3 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

6 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

6 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

6 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

6 hours ago